Is the German cannabis boom outrunning the rules that created it?
Germany medical cannabis imports in 2026 are still climbing fast, even as Berlin moves to tighten the very prescribing rules that unlocked the boom. Two months ago we mapped the European cannabis import race and Germany’s remarkable 2025 growth. The latest quarterly figures show the surge has not slowed, and a new tension has emerged: supply is accelerating at the exact moment German lawmakers are moving to cool the demand that fuelled it.
Germany medical cannabis imports: what the Q1 2026 data shows
Germany imported 50,539 kg of medical cannabis in the first quarter of 2026, according to data from the Federal Institute for Drugs and Medical Devices (BfArM). Canada was the largest supplier by a wide margin, shipping 26,753 kg, or 53% of the total, with Portugal second at 10,342 kg as Europe’s main processing hub. Combined with the back half of 2025, Germany has now imported more than 218 tonnes in a rolling twelve-month window. For the full 2025 calendar year, imports reached 201 tonnes and German medical cannabis sales crossed one billion euros.
Who is supplying Germany in 2026
| Supplier (Q1 2026) | Volume | Share |
|---|---|---|
| Canada | 26,753 kg | 53% |
| Portugal | 10,342 kg | ~20% |
| All other countries | ~13,444 kg | ~27% |
| Total imports | 50,539 kg | 100% |
Notably, Canada has strengthened its lead rather than losing ground. Earlier in the cycle its share appeared to be slipping even as absolute volumes grew; the Q1 2026 data reverses that narrative, putting Canadian producers back above half of all German imports. You can read the earlier picture in our European cannabis import race analysis.
Why Germany is moving to cool the market
At the same time as imports climb, Germany is moving to tighten the rules that drove the boom. A draft amendment to the medical cannabis act, approved by the Federal Cabinet in October 2025, would require in-person doctor contact for cannabis flower prescriptions and restrict telemedicine-only prescribing and mail-order marketing. The bill had its first Bundestag reading in December 2025 and went to committee in January 2026, with further readings expected in spring 2026.
It is not yet law, and it is contested. The Bundesrat backed tighter prescribing rules but rejected the mail-order penalties, and members of the SPD have said they will not approve the draft in its current form. Telemedicine prescribing and mail-order fulfilment are precisely the mechanisms that unlocked demand after the Cannabis Act removed cannabis from the narcotics schedule in April 2024, so any restriction directly targets the growth engine.
What does this mean for cannabis producers?
For cultivators and processors, this is the central strategic question of 2026: producers are pouring capital into EU-GMP capacity, which still costs between 2.5 and 11 million euros and takes 18 to 36 months to stand up, into a market that regulators are actively trying to cool. Two signals point in opposite directions. On the supply side, demand is still growing and Canada has strengthened its lead. On the regulatory side, the mechanisms that unlocked that demand are now the target of legislation.
The operators best positioned to absorb that uncertainty are the ones who can prove quality and traceability on demand, move quickly on export documentation, and control their supply chain end to end.
Four moves worth making now
- Watch the German amendment through its spring 2026 readings before committing to long-term supply contracts sized to current telemedicine-driven volume.
- Pressure-test your EU-GMP timeline and cost assumptions. The 18-to-36-month runway means capacity decisions made now land in a very different regulatory climate.
- Diversify target markets. Germany is roughly 40% of European demand, but the UK, Poland, and the Czech Republic are expanding, and single-market exposure is a real risk if German demand softens.
- Tighten quality and traceability systems now, so audit readiness and export documentation are never the bottleneck when a purchase order arrives.
How GrowerIQ helps producers stay export-ready
GrowerIQ’s seed-to-sale platform gives producers the batch and lot traceability, quality management, and documentation trail that EU-GMP markets demand, all in one system. When an importer or auditor asks you to prove the chain of custody on a lot, or when an export permit hinges on complete records, having that data ready rather than reconstructed is the difference between shipping and stalling. In a market where regulatory conditions can shift between the readings of a bill, staying continuously audit- and export-ready is the most durable advantage a producer can build.
Key takeaways
- Germany medical cannabis imports hit 50,539 kg in Q1 2026; the rolling twelve-month total now exceeds 218 tonnes.
- Canada strengthened its lead to 53% of imports; Portugal is second as Europe’s processing hub.
- A draft law to restrict telemedicine prescribing and mail-order is advancing but contested, not yet enacted.
- Producers are building EU-GMP capacity into a market regulators are trying to cool, raising the value of traceability and export readiness.
Sources
- Canada Supplied Half Germany’s Cannabis Imports in Q1 2026 (BfArM data), StratCann
- Canada Dominates German Medical Cannabis Imports in Q1 2026, Hemp Gazette
- Germany Imported Over 218 Tons of Legal Cannabis in One Year, Cannabis Law Report
- Germany Imports 201 Tonnes of Medical Cannabis in 2025 and Crosses 1 Billion Euros in Sales, Cannamonitor
- German Federal Government to Prohibit Telemedical Prescriptions of Medical Cannabis, Gleiss Lutz
- Bundesrat Backs Tighter Cannabis Prescribing Rules, Rejects Mail-Order Penalties, Business of Cannabis
Last updated: July 10, 2026
Building for the EU-GMP export market?
See how GrowerIQ’s seed-to-sale platform keeps your batch traceability and quality records audit- and export-ready, so a purchase order never waits on paperwork.
REQUEST DEMO
About GrowerIQ
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.